• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Shionogi

Pharma

Eisai, BeiGene, Shionogi—Fierce Pharma Asia

Eisai fields lecanemab safety questions in its full data release. BeiGene's Brukinsa betas Imbruvica in CLL. Shionogi's COVID drug snags first nod.
Angus Liu Dec 2, 2022 10:00am

ViiV Healthcare finds HIV stigma still stubbornly high

Dec 2, 2022 9:40am

Shionogi drug to compete with Paxlovid and Lagevrio in Japan

Nov 22, 2022 11:18am

Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia

Sep 30, 2022 9:15am

COVID-19 tracker: Pfizer, AstraZeneca, Moderna and more

Aug 31, 2022 11:15am

Biocon, AstraZeneca, Shionogi—Fierce Pharma Asia

Jun 24, 2022 9:10am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy